tiprankstipranks
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Income Statement

Compare
486 Followers

Fulcrum Therapeutics Income Statement

Last quarter (Q2 2024), Fulcrum Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Fulcrum Therapeutics's net income was $-21.70M. See Fulcrum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.81M$ 6.34M$ 19.16M$ 8.82M$ 0.00
Gross Profit
$ 2.81M$ 3.93M$ 16.65M$ 6.44M$ -2.05M
Operating Expenses
$ 113.47M$ 118.48M$ 100.22M$ 80.43M$ 84.22M
Depreciation and Amortization
$ 2.17M$ 2.41M$ 2.52M$ 2.38M$ 2.05M
EBITDA
$ -108.49M$ -109.72M$ -78.54M$ -69.23M$ -82.16M
Operating Income
$ -110.66M$ -112.56M$ -81.05M$ -71.61M$ -84.22M
Other Income/Expenses
$ 13.33M$ 2.69M$ 207.00K$ 792.00K$ 1.54M
Pretax Income
$ -97.33M$ -109.87M$ -80.85M$ -70.82M$ -82.68M
Net Income
$ -97.33M$ -105.62M$ -78.33M$ -68.44M$ -79.11M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.59$ -2.35$ -2.22$ -2.70$ -7.16
Diluted EPS
$ -1.59$ -2.35$ -2.22$ -2.70$ -7.16
Weighted Average Shares Outstanding
61.31M 44.99M 35.36M 25.35M 11.05M
Weighted Average Shares Outstanding (Diluted)
61.31M 44.99M 35.36M 25.35M 11.05M
Currency in USD

Fulcrum Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis